Back to top

Cantor Fitzgerald Assigns Overweight Rating to EPRX with $11 Price Target | EPRX Stock News

Cantor Fitzgerald Assigns Overweight Rating to EPRX with $11 Price Target | EPRX Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Eupraxia Pharmaceuticals Inc. (EPRX)